High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis

Journal of Translational Medicine

Volumn 7, Issue , 2009, Pages

  Yeom, Chang Hwan ^a   Lee, Gunsup ^b   Park, Jin Hee ^b   Yu, Jaelim ^b   Park, Seyeon ^c   Yi, Sang Yeop ^d   Lee, Hye ^e   Hong, Young Seon ^a   Yang, Joosung ^b   Lee, Suckchan ^b  

^a The Catholic University of Korea   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Dongduk Women's University   (South Korea)

^d Catholic Kwandong University   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; BASIC FIBROBLAST GROWTH FACTOR; GELATINASE A; VASCULOTROPIN; ANTINEOPLASTIC AGENT; ANTIOXIDANT; FIBROBLAST GROWTH FACTOR 2; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BODY WEIGHT; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; GENE EXPRESSION; LOW DRUG DOSE; MIGRATION INHIBITION; MOUSE; NONHUMAN; SARCOMA; SURVIVAL RATE; ANIMAL; ASCITES; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CELL MOTION; CELL STRAIN 3T3; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; ASCITES; ASCORBIC ACID; CELL LINE, TUMOR; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NIH 3T3 CELLS; SARCOMA; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 69349096333     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-7-70     Document Type: Article

References (43)

1. Jemal A Thun MJ Ries LA Howe HL Weir HK Center MM Ward E Wu XC Eheman C Anderson R et al Annual report to the nation on the status of cancer, 19752005featuring trends in lung cancer, tobacco use, and tobacco control J Natl Cancer Inst 2008, 100:1672-1694. 10.1093/jnci/djn389 2639291 19033571
2. Gonzalez MJ Miranda-Massari JR Mora EM Guzman A Riordan NH Riordan HD Casciari JJ Jackson JA Roman-Franco A Orthomolecular oncology review: ascorbic acid and cancer 25 years later Integr Cancer Ther 2005, 4:32-44. 10.1177/1534735404273861 15695476
3. Klenner FR The treatment of poliomyelitis and other virus diseases with vitamin C South Med Surg 1949, 111:209-214. 18147027
4. Cameron E Pauling L Leibovitz B Ascorbic acid and cancer: A review Cancer Res 1979, 39:663-681. 371790
5. Chen Q Espey MG Krishna MC Mitchell JB Corpe CP Buettner GR Shacter E Levine M Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues Proc Natl Acad Sci USA 2005, 102:13604-13609. 10.1073/ pnas.0506390102 1224653 16157892
6. Chen Q Espey MG Sun AY Lee JH Krishna MC Shacter E Choyke PL Pooput C Kirk KL Buettner GR Levine M Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo Proc Natl Acad Sci USA 2007, 104:8749-8754. 10.1073/pnas.0702854104 1885574 17502596
7. Padayatty SJ Riordan HD Hewitt SM Katz A Hoffer LJ Levine M Intravenously administered vitamin C as cancer therapy: Three cases CMAJ 2006, 174:937-942. 1405876 16567755
8. Frei B Lawson S Vitamin C and cancer revisited Proc Natl Acad Sci USA 2008, 105:11037-11038. 10.1073/pnas.0806433105 2516245 18682554
9. de la Lastra CA Villegas I Resveratrol as an antioxidant and pro-oxidant agent: Mechanisms and clinical implications Biochem Soc Trans 2007, 35:1156-1160. 10.1042/BST0351156 17956300
10. Mikirova NA Ichim TE Riordan NH Anti-angiogenic effect of high doses of ascorbic acid J Transl Med 2008, 6:50. 10.1186/1479-5876-6-50 2562367 18789157
11. Peyman GA Kivilcim M Morales AM DellaCroce JT Conway MD Inhibition of corneal angiogenesis by ascorbic acid in the rat model Graefes Arch Clin Exp Ophthalmol 2007, 245:11461-1467. 10.1007/s00417-007-0542-4 17318569
12. Park S Ahn ES Lee S Jung M Park JH Yi SY Yeom CH Proteomic analysis reveals upregulation of RKIP in S-180 implanted BALB/C mouse after treatment with ascorbic acid J Cell Biochem 2009, 106:1136-1145. 10.1002/ jcb.22097 19224539
13. Chomczynski P aMK Short technical report. Modification of the TRIZOL reagent procedure for isolation of RNA from Polysaccharide-and proteoglycan-rich sources Biotechniques 1995, 19:942-945. 8747660
14. Lynch MJRS Mellor LD Spare PD Inwood JH Medical Laboratory Technology and Clinical Pathology Philadelphia: W. B. Saunders Co 2 1969.
15. McLane MA Zhang X Tian J Zelinskas C Srivastava A Hensley B Paquette-Straub C Scratching below the surface: Wound healing and alanine mutagenesis provide unique insights into interactions between eristostatin, platelets and melanoma cells Pathophysiol Haemost Thromb 2005, 34:164-168. 10.1159/000092417 16707921
16. Barness LA Safety considerations with high ascorbic acid dosage Ann N Y Acad Sci 1975, 258:523-528. 10.1111/j.1749-6632.1975.tb29311.x 946
17. Mayland CR Bennett MI Allan K Vitamin C deficiency in cancer patients Palliat Med 2005, 19:17-20. 10.1191/0269216305pm970oa 15690864
18. Folkman J Tumor angiogenesis: Therapeutic implications N Engl J Med 1971, 285:1182-1186. 4938153
19. Folkman J Tumor angiogenesis Adv Cancer Res 1985, 43:175-203. 10.1016/ S0065-230X(08)60946-X 2581424
20. Folkman J Fundamental concepts of the angiogenic process Curr Mol Med 2003, 3:643-651. 10.2174/1566524033479465 14601638
21. Di Blasio AM Carniti C Vigano P Vignali M Basic fibroblast growth factor and ovarian cancer J Steroid Biochem Mol Biol 1995, 53:375-379. 10.1016/ 0960-0760(95)00082-B 7626484
22. Crickard K Gross JL Crickard U Yoonessi M Lele S Herblin WF Eidsvoog K Basic fibroblast growth factor and receptor expression in human ovarian cancer Gynecol Oncol 1994, 55:277-284. 10.1006/gyno.1994.1290 7959296
23. Montesano R Vassalli JD Baird A Guillemin R Orci L Basic fibroblast growth factor induces angiogenesis in vitro Proc Natl Acad Sci USA 1986, 83:7297-7301. 10.1073/pnas.83.19.7297 386703 2429303
24. Johnston CL Cox HC Gomm JJ Coombes RC bFGF and aFGF induce membrane ruffling in breast cancer cells but not in normal breast epithelial cells: FGFR-4 involvement Biochem J 1995, 306(Pt 2):609-616. 1136561 7534069
25. Connolly DT Heuvelman DM Nelson R Olander JV Eppley BL Delfino JJ Siegel NR Leimgruber RM Feder J Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis J Clin Invest 1989, 84:1470-1478. 10.1172/JCI114322 304011 2478587
26. Plate KH Breier G Weich HA Risau W Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo Nature 1992, 359:845-848. 10.1038/359845a0 1279432
27. Ramakrishnan S Olson TA Bautch VL Mohanraj D Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo Cancer Res 1996, 56:1324-1330. 8640821
28. Yamamoto S Konishi I Mandai M Kuroda H Komatsu T Nanbu K Sakahara H Mori T Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: Correlation with clinicopathology and patient survival, and analysis of serum VEGF levels Br J Cancer 1997, 76:1221-1227. 9365173
29. Karavasilis V Malamou-Mitsi V Briasoulis E Tsanou E Kitsou E Kalofonos H Fountzilas G Fotsis T Pavlidis N Angiogenesis in cancer of unknown primary: Clinicopathological study of CD34, VEGF and TSP-1 BMC Cancer 2005, 5:25. 10.1186/1471-2407-5-25 555600 15743540
30. Staack A Badendieck S Schnorr D Loening SA Jung K Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder BMC Urol 2006, 6:19. 10.1186/ 1471-2490-6-19 1560390 16901349
31. Roomi MW Ivanov V Kalinovsky T Niedzwiecki A Rath M In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on human fibrosarcoma cells HT-1080 Med Oncol 2006, 23:105-111. 10.1385/MO:23:1:105 16645235
32. Roomi MW Ivanov V Netke S Kalinovsky T Niedzwiecki A Rath M In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline and green tea extract on human melanoma cell line A2058 In Vivo 2006, 20:25-32. 16433024
33. Roomi MW Roomi N Ivanov V Kalinovsky T Niedzwiecki A Rath M Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angiogenesis Oncol Rep 2005, 14:807-815. 16142336
34. Ashino H Shimamura M Nakajima H Dombou M Kawanaka S Oikawa T Iwaguchi T Kawashima S Novel function of ascorbic acid as an angiostatic factor Angiogenesis 2003, 6:259-269. 10.1023/B:AGEN.0000029390.09354.f8 15166494
35. Fain O Mathieu E Thomas M Scurvy in patients with cancer BMJ 1998, 316:1661-1662. 1113239 9603754
36. Chan AC Partners in defense, vitamin E and vitamin C Can J Physiol Pharmacol 1993, 71:725-731. 8313238
37. Frei B England L Ames BN Ascorbate is an outstanding antioxidant in human blood plasma Proc Natl Acad Sci USA 1989, 86:6377-6381. 10.1073/ pnas.86.16.6377 297842 2762330
38. Levine M Dhariwal KR Washko PW Butler JD Welch RW Wang YH Bergsten P Ascorbic acid and in situ kinetics: A new approach to vitamin requirements Am J Clin Nutr 1991, 54:1157S-1162S. 1962564
39. Niki E Action of ascorbic acid as a scavenger of active and stable oxygen radicals Am J Clin Nutr 1991, 54:1119S-1124S. 1962557
40. Mirvish SS Experimental evidence for inhibition of N-nitroso compound formation as a factor in the negative correlation between vitamin C consumption and the incidence of certain cancers Cancer Res 1994, 54:1948s-1951s. 8137317
41. Eckardt KU Bernhardt W Willam C Wiesener M Hypoxia-inducible transcription factors and their role in renal disease Semin Nephrol 2007, 27:363-372. 10.1016/j.semnephrol.2007.02.007 17533012
42. Jones DT Trowbridge IS Harris AL Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbate Cancer Res 2006, 66:2749-2756. 10.1158/0008-5472.CAN-05-3857 16510596
43. Drisko JA Chapman J Hunter VJ The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer J Am Coll Nutr 2003, 22:118-123. 12672707